WSO October 2023 – Issue 1 - 1003

Ryan et al.
1003
Table 3. Results of multilevel regression modelinga examining the effect of the experimental (ASK) versus attention control (SSPIP)
interventions on outcomes.
Outcomes
SADQ-21 Total
Attention Control (ref: ASK group)
ALA Total
Attention Control (ref: ASK group)
SRRB Total
Attention Control (ref: ASK group)
GHQ-28 Total
Attention Control (ref: ASK group)
BCOS Total
Attention Control (ref: ASK group)
Intention-to-treat analysis
β (95% CI), p value
−2.74 (−4.76 to −0.73), 0.008**
n = 122, 17 clusters
−0.39 (−5.0 to 4.19), 0.87
n = 140, 18 clusters
−0.09 (−0.41 to 0.23), 0.58
n = 141, 18 clusters
−3.19 (−6.45 to 0.08), 0.06
n = 82, 16 clusters
2.60 (−1.66 to 6.84), 0.23
n = 76, 16 clusters
Per-protocol analysis
β (95% CI), p value
−2.38 (−4.71 to −0.07), 0.04*
n = 52, 13 clusters
−4.2 (−.1.95 to 10.43), 0.18
n = 59, 13 clusters
−0.18 (−0.27 to 0.64), 0.43
n = 58, 13 clusters
−1.01 (−5.90 to −3.87), 0.68
n = 33, 10 clusters
−0.19 (−7.23 to 6.85), 0.96
n = 31, 11 clusters
Per-protocol analysis for participants who had pre- and post-outcome measures, who completed 3 or more face-to-face sessions and where
intervention was delivered by a therapist who passed the treatment fidelity check.
β: adjusted regression coefficient; CI: confidence interval; SADQ-21: Stroke and Aphasia Depression Questionnaire-21; ASK: Action Success
Knowledge; ALA: Assessment for living with Aphasia; GHQ-28: General Health Questionnaire-28; BCOS: Bakas Caregiving Outcomes Scale-
Revised; WAB-AQ: Western Aphasia Battery-Aphasia Quotient.
aAdjusted for age, gender, educational level, living situation, walking status, and WAB-AQ baseline measure at time 1.
*Significant at α < 0.05.
**Significant at α < 0.01.
and could include co-designing interventions, providing
secondary stroke prevention information and discussion,
and training speech pathologists in psychosocial education
techniques and counseling.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect
to the research, authorship, and/or publication of this article.
Funding
The author(s) disclosed receipt of the following financial support
for the research, authorship, and/or publication of this article:
National Health and Medical Research grant APP1060673.
Trial registration
Australian Clinical Trials ACTRN12614000979651
ORCID iDs
Brooke Ryan
Ian Kneebone
Miranda L. Rose
Leanne Togher
https://orcid.org/0000-0002-6053-7614
https://orcid.org/0000-0003-3324-7264
https://orcid.org/0000-0002-8892-0965
https://orcid.org/0000-0002-4518-6748
Data availability
Ethical clearance for sharing data was not obtained.
Supplemental material
Supplemental material for this article is available online.
References
1. Hilari K, Northcott S, Roy P, et al. Psychological distress after
stroke and aphasia: the first six months. Clin Rehabil 2010;
24: 181-190.
2. House A, Knapp P, Bamford J and Vail A. Mortality at 12 and
24 months after stroke may be associated with depressive
symptoms at 1 month. Stroke 2001; 32: 696-701.
3. Bakas T, Kroenke K, Plue LD, Perkins SM and Williams LS.
Outcomes among family caregivers of aphasic versus nonaphasic
stroke survivors. Rehabil Nurs 2006; 31: 33-42.
4. Cruice M, Worrall L, Hickson L, et al. Finding focus for quality
of life with aphasia: social & emotional health, & psychological
well-being. Aphasiology 2003; 17: 333-353.
5. Worrall LE, Hudson K, Khan A, Ryan B and SimmonsMackie
N. Determinants of living well with aphasia in the
first year poststroke: a prospective cohort study. Arch Phys
Med Rehabil 2017; 98: 235-240.
6. Legg LA, Rudberg A-S, Hua X, et al. Selective serotonin
reuptake inhibitors (SSRIs) for stroke recovery. Cochrane
Database Syst Rev 2021; 11: CD009286.
7. Baker C, Worrall L, Rose M, Hudson K, Ryan B and O'Byrne L.
A systematic review of rehabilitation interventions to prevent
and treat depression in post-stroke aphasia. Disabil Rehabil
2018; 40: 1870-1892.
8. Sutcliffe LM and Lincoln NB. The assessment of depression in
aphasic stroke patients: the development of the Stroke Aphasic
Depression Questionnaire. Clin Rehabil 1998; 12: 506-513.
9. Kagan A, Simmons-Mackie N, Victor JC, et al. Assessment for
living with aphasia. Toronto, OH: Aphasia Institute, 2010.
10. Bakas T, Champion V, Perkins SM, Farran CJ and Williams
LS. Psychometric testing of the
Caregiving Outcomes Scale. Nurs Res 2006; 55: 346-355.
International Journal of Stroke, 18(8)
revised 15-item Bakas
https://www.orcid.org/0000-0002-6053-7614 https://www.orcid.org/0000-0003-3324-7264 https://www.orcid.org/0000-0002-8892-0965 https://www.orcid.org/0000-0002-4518-6748

WSO October 2023 – Issue 1

Table of Contents for the Digital Edition of WSO October 2023 – Issue 1

Contents
WSO October 2023 – Issue 1 - Cover1
WSO October 2023 – Issue 1 - Cover2
WSO October 2023 – Issue 1 - 879
WSO October 2023 – Issue 1 - Contents
WSO October 2023 – Issue 1 - 881
WSO October 2023 – Issue 1 - 882
WSO October 2023 – Issue 1 - 883
WSO October 2023 – Issue 1 - 884
WSO October 2023 – Issue 1 - 885
WSO October 2023 – Issue 1 - 886
WSO October 2023 – Issue 1 - 887
WSO October 2023 – Issue 1 - 888
WSO October 2023 – Issue 1 - 889
WSO October 2023 – Issue 1 - 890
WSO October 2023 – Issue 1 - 891
WSO October 2023 – Issue 1 - 892
WSO October 2023 – Issue 1 - 893
WSO October 2023 – Issue 1 - 894
WSO October 2023 – Issue 1 - 895
WSO October 2023 – Issue 1 - 896
WSO October 2023 – Issue 1 - 897
WSO October 2023 – Issue 1 - 898
WSO October 2023 – Issue 1 - 899
WSO October 2023 – Issue 1 - 900
WSO October 2023 – Issue 1 - 901
WSO October 2023 – Issue 1 - 902
WSO October 2023 – Issue 1 - 903
WSO October 2023 – Issue 1 - 904
WSO October 2023 – Issue 1 - 905
WSO October 2023 – Issue 1 - 906
WSO October 2023 – Issue 1 - 907
WSO October 2023 – Issue 1 - 908
WSO October 2023 – Issue 1 - 909
WSO October 2023 – Issue 1 - 910
WSO October 2023 – Issue 1 - 911
WSO October 2023 – Issue 1 - 912
WSO October 2023 – Issue 1 - 913
WSO October 2023 – Issue 1 - 914
WSO October 2023 – Issue 1 - 915
WSO October 2023 – Issue 1 - 916
WSO October 2023 – Issue 1 - 917
WSO October 2023 – Issue 1 - 918
WSO October 2023 – Issue 1 - 919
WSO October 2023 – Issue 1 - 920
WSO October 2023 – Issue 1 - 921
WSO October 2023 – Issue 1 - 922
WSO October 2023 – Issue 1 - 923
WSO October 2023 – Issue 1 - 924
WSO October 2023 – Issue 1 - 925
WSO October 2023 – Issue 1 - 926
WSO October 2023 – Issue 1 - 927
WSO October 2023 – Issue 1 - 928
WSO October 2023 – Issue 1 - 929
WSO October 2023 – Issue 1 - 930
WSO October 2023 – Issue 1 - 931
WSO October 2023 – Issue 1 - 932
WSO October 2023 – Issue 1 - 933
WSO October 2023 – Issue 1 - 934
WSO October 2023 – Issue 1 - 935
WSO October 2023 – Issue 1 - 936
WSO October 2023 – Issue 1 - 937
WSO October 2023 – Issue 1 - 938
WSO October 2023 – Issue 1 - 939
WSO October 2023 – Issue 1 - 940
WSO October 2023 – Issue 1 - 941
WSO October 2023 – Issue 1 - 942
WSO October 2023 – Issue 1 - 943
WSO October 2023 – Issue 1 - 944
WSO October 2023 – Issue 1 - 945
WSO October 2023 – Issue 1 - 946
WSO October 2023 – Issue 1 - 947
WSO October 2023 – Issue 1 - 948
WSO October 2023 – Issue 1 - 949
WSO October 2023 – Issue 1 - 950
WSO October 2023 – Issue 1 - 951
WSO October 2023 – Issue 1 - 952
WSO October 2023 – Issue 1 - 953
WSO October 2023 – Issue 1 - 954
WSO October 2023 – Issue 1 - 955
WSO October 2023 – Issue 1 - 956
WSO October 2023 – Issue 1 - 957
WSO October 2023 – Issue 1 - 958
WSO October 2023 – Issue 1 - 959
WSO October 2023 – Issue 1 - 960
WSO October 2023 – Issue 1 - 961
WSO October 2023 – Issue 1 - 962
WSO October 2023 – Issue 1 - 963
WSO October 2023 – Issue 1 - 964
WSO October 2023 – Issue 1 - 965
WSO October 2023 – Issue 1 - 966
WSO October 2023 – Issue 1 - 967
WSO October 2023 – Issue 1 - 968
WSO October 2023 – Issue 1 - 969
WSO October 2023 – Issue 1 - 970
WSO October 2023 – Issue 1 - 971
WSO October 2023 – Issue 1 - 972
WSO October 2023 – Issue 1 - 973
WSO October 2023 – Issue 1 - 974
WSO October 2023 – Issue 1 - 975
WSO October 2023 – Issue 1 - 976
WSO October 2023 – Issue 1 - 977
WSO October 2023 – Issue 1 - 978
WSO October 2023 – Issue 1 - 979
WSO October 2023 – Issue 1 - 980
WSO October 2023 – Issue 1 - 981
WSO October 2023 – Issue 1 - 982
WSO October 2023 – Issue 1 - 983
WSO October 2023 – Issue 1 - 984
WSO October 2023 – Issue 1 - 985
WSO October 2023 – Issue 1 - 986
WSO October 2023 – Issue 1 - 987
WSO October 2023 – Issue 1 - 988
WSO October 2023 – Issue 1 - 989
WSO October 2023 – Issue 1 - 990
WSO October 2023 – Issue 1 - 991
WSO October 2023 – Issue 1 - 992
WSO October 2023 – Issue 1 - 993
WSO October 2023 – Issue 1 - 994
WSO October 2023 – Issue 1 - 995
WSO October 2023 – Issue 1 - 996
WSO October 2023 – Issue 1 - 997
WSO October 2023 – Issue 1 - 998
WSO October 2023 – Issue 1 - 999
WSO October 2023 – Issue 1 - 1000
WSO October 2023 – Issue 1 - 1001
WSO October 2023 – Issue 1 - 1002
WSO October 2023 – Issue 1 - 1003
WSO October 2023 – Issue 1 - 1004
WSO October 2023 – Issue 1 - 1005
WSO October 2023 – Issue 1 - 1006
WSO October 2023 – Issue 1 - 1007
WSO October 2023 – Issue 1 - 1008
WSO October 2023 – Issue 1 - 1009
WSO October 2023 – Issue 1 - 1010
WSO October 2023 – Issue 1 - 1011
WSO October 2023 – Issue 1 - 1012
WSO October 2023 – Issue 1 - 1013
WSO October 2023 – Issue 1 - 1014
WSO October 2023 – Issue 1 - 1015
WSO October 2023 – Issue 1 - 1016
WSO October 2023 – Issue 1 - 1017
WSO October 2023 – Issue 1 - 1018
WSO October 2023 – Issue 1 - 1019
WSO October 2023 – Issue 1 - 1020
WSO October 2023 – Issue 1 - Cover3
WSO October 2023 – Issue 1 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com